473 related articles for article (PubMed ID: 37627173)
1. Nanomedicine Strategies for Targeting Tumor Stroma.
Su MC; Nethi SK; Dhanyamraju PK; Prabha S
Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627173
[TBL] [Abstract][Full Text] [Related]
2. Emerging Nano Drug Delivery Systems Targeting Cancer-Associated Fibroblasts for Improved Antitumor Effect and Tumor Drug Penetration.
Guo J; Zeng H; Chen Y
Mol Pharm; 2020 Apr; 17(4):1028-1048. PubMed ID: 32150417
[TBL] [Abstract][Full Text] [Related]
3. Strategies for Efficient Targeting of Tumor Collagen for Cancer Therapy.
Baldari S; Di Modugno F; Nisticò P; Toietta G
Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230627
[TBL] [Abstract][Full Text] [Related]
4. Targeting Tumor-Stromal Interactions in Pancreatic Cancer: Impact of Collagens and Mechanical Traits.
Maneshi P; Mason J; Dongre M; Öhlund D
Front Cell Dev Biol; 2021; 9():787485. PubMed ID: 34901028
[TBL] [Abstract][Full Text] [Related]
5. Modulating the Tumor Microenvironment to Enhance Tumor Nanomedicine Delivery.
Zhang B; Hu Y; Pang Z
Front Pharmacol; 2017; 8():952. PubMed ID: 29311946
[TBL] [Abstract][Full Text] [Related]
6. Macrophages and Fibroblasts, Key Players in Cancer Chemoresistance.
Ireland LV; Mielgo A
Front Cell Dev Biol; 2018; 6():131. PubMed ID: 30356656
[TBL] [Abstract][Full Text] [Related]
7. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.
Dzobo K; Dandara C
OMICS; 2020 Jun; 24(6):314-339. PubMed ID: 32496970
[TBL] [Abstract][Full Text] [Related]
8. The Extracellular Matrix in Pancreatic Cancer: Description of a Complex Network and Promising Therapeutic Options.
Ferrara B; Pignatelli C; Cossutta M; Citro A; Courty J; Piemonti L
Cancers (Basel); 2021 Sep; 13(17):. PubMed ID: 34503252
[TBL] [Abstract][Full Text] [Related]
9. Perspective of Targeting Cancer-Associated Fibroblasts in Melanoma.
Zhou L; Yang K; Andl T; Wickett RR; Zhang Y
J Cancer; 2015; 6(8):717-26. PubMed ID: 26185533
[TBL] [Abstract][Full Text] [Related]
10. Recent Advances in Strategies for Extracellular Matrix Degradation and Synthesis Inhibition for Improved Therapy of Solid Tumors.
Sandha KK; Shukla MK; Gupta PN
Curr Pharm Des; 2020; 26(42):5456-5467. PubMed ID: 32723249
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic Remodeling of the Tumor Microenvironment Enhances Nanoparticle Delivery.
Chen Y; Liu X; Yuan H; Yang Z; von Roemeling CA; Qie Y; Zhao H; Wang Y; Jiang W; Kim BYS
Adv Sci (Weinh); 2019 Mar; 6(5):1802070. PubMed ID: 30886813
[TBL] [Abstract][Full Text] [Related]
12. Regulation of heterogeneous cancer-associated fibroblasts: the molecular pathology of activated signaling pathways.
Yoshida GJ
J Exp Clin Cancer Res; 2020 Jun; 39(1):112. PubMed ID: 32546182
[TBL] [Abstract][Full Text] [Related]
13. Hyaluronan, Cancer-Associated Fibroblasts and the Tumor Microenvironment in Malignant Progression.
McCarthy JB; El-Ashry D; Turley EA
Front Cell Dev Biol; 2018; 6():48. PubMed ID: 29868579
[TBL] [Abstract][Full Text] [Related]
14. Stroma-targeting strategies in pancreatic cancer: a double-edged sword.
Liu X; Iovanna J; Santofimia-Castaño P
J Physiol Biochem; 2023 Feb; 79(1):213-222. PubMed ID: 36580230
[TBL] [Abstract][Full Text] [Related]
15. 3D is not enough: Building up a cell instructive microenvironment for tumoral stroma microtissues.
Brancato V; Garziano A; Gioiella F; Urciuolo F; Imparato G; Panzetta V; Fusco S; Netti PA
Acta Biomater; 2017 Jan; 47():1-13. PubMed ID: 27721010
[TBL] [Abstract][Full Text] [Related]
16. Imaging aspects of the tumor stroma with therapeutic implications.
Narunsky L; Oren R; Bochner F; Neeman M
Pharmacol Ther; 2014 Feb; 141(2):192-208. PubMed ID: 24134903
[TBL] [Abstract][Full Text] [Related]
17. Targeting the tumor stroma for cancer therapy.
Xu M; Zhang T; Xia R; Wei Y; Wei X
Mol Cancer; 2022 Nov; 21(1):208. PubMed ID: 36324128
[TBL] [Abstract][Full Text] [Related]
18. Partial ligand shielding nanoparticles improve pancreatic ductal adenocarcinoma treatment via a multifunctional paradigm for tumor stroma reprogramming.
Zhao T; Zhang R; He Q; Zhou H; Song X; Gong T; Zhang Z
Acta Biomater; 2022 Jun; 145():122-134. PubMed ID: 35381402
[TBL] [Abstract][Full Text] [Related]
19. Nanomedicine Strategies to Enhance Tumor Drug Penetration in Pancreatic Cancer.
Lu T; Prakash J
Int J Nanomedicine; 2021; 16():6313-6328. PubMed ID: 34552327
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer cells alter the dynamics of stromal fibronectin-collagen interactions.
Wang K; Wu F; Seo BR; Fischbach C; Chen W; Hsu L; Gourdon D
Matrix Biol; 2017 Jul; 60-61():86-95. PubMed ID: 27503584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
